Suit Says Sanofi Held Back Info On Obesity Drug
French pharmaceutical giant Sanofi-Aventis has been hit with a putative securities class action accusing it and five individuals of withholding information about anti-obesity drug Zimulti's tendency to cause severe psychiatric problems,...To view the full article, register now.
Already a subscriber? Click here to view full article